Annual ROE
443.51%
+1720.52%+134.73%
December 31, 2023
Summary
- As of February 8, 2025, TCON annual return on equity is 443.51%, with the most recent change of +1720.52% (+134.73%) on December 31, 2023.
- During the last 3 years, TCON annual ROE has risen by +564.32% (+467.11%).
- TCON annual ROE is now at all-time high.
Performance
TCON ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-237.65%
-204.97%-627.20%
June 30, 2024
Summary
- As of February 8, 2025, TCON quarterly return on equity is -237.65%, with the most recent change of -204.97% (-627.20%) on June 30, 2024.
- Over the past year, TCON quarterly ROE has dropped by -284.39% (-608.45%).
- TCON quarterly ROE is now -138.64% below its all-time high of 615.11%, reached on March 31, 2023.
Performance
TCON Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
TCON ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +134.7% | -608.5% |
| 3 y3 years | +467.1% | +25.1% |
| 5 y5 years | +343.8% | -73.2% |
TCON ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +134.7% | -138.6% | +88.2% |
| 5 y | 5-year | at high | +134.7% | -138.6% | +88.2% |
| alltime | all time | at high | +134.7% | -138.6% | +88.2% |
TRACON Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | -237.65%(+627.2%) |
| Mar 2024 | - | -32.68%(-169.9%) |
| Dec 2023 | 443.51%(-134.7%) | 46.74%(-60.7%) |
| Sep 2023 | - | 119.03%(-61.4%) |
| Jun 2023 | - | 308.46%(-49.9%) |
| Mar 2023 | - | 615.11%(-130.7%) |
| Dec 2022 | -1277.01%(+719.3%) | -2006.54%(+347.3%) |
| Sep 2022 | - | -448.55%(+41.3%) |
| Jun 2022 | - | -317.49%(+26.0%) |
| Mar 2022 | - | -251.95%(+54.5%) |
| Dec 2021 | -155.86%(+29.0%) | -163.03%(+18.3%) |
| Sep 2021 | - | -137.78%(-6.3%) |
| Jun 2021 | - | -147.07%(+10.1%) |
| Mar 2021 | - | -133.56%(-21.9%) |
| Dec 2020 | -120.81%(-35.7%) | -171.02%(-41.6%) |
| Sep 2020 | - | -292.79%(-28.7%) |
| Jun 2020 | - | -410.63%(+40.1%) |
| Mar 2020 | - | -293.04%(+34.2%) |
| Dec 2019 | -187.85%(+3.2%) | -218.44%(+28.2%) |
| Sep 2019 | - | -170.36%(+24.1%) |
| Jun 2019 | - | -137.24%(+17.1%) |
| Mar 2019 | - | -117.18%(-1.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | -181.94%(+115.8%) | -119.37%(+3.8%) |
| Sep 2018 | - | -114.99%(+32.6%) |
| Jun 2018 | - | -86.72%(+3.8%) |
| Mar 2018 | - | -83.57%(-6.0%) |
| Dec 2017 | -84.30%(-7.4%) | -88.92%(+2.1%) |
| Sep 2017 | - | -87.12%(-29.7%) |
| Jun 2017 | - | -123.92%(+0.9%) |
| Mar 2017 | - | -122.77%(+9.6%) |
| Dec 2016 | -91.07%(+15.6%) | -112.06%(-5.9%) |
| Sep 2016 | - | -119.12%(+19.6%) |
| Jun 2016 | - | -99.60%(+42.9%) |
| Mar 2016 | - | -69.68%(-22.5%) |
| Dec 2015 | -78.80%(-472.4%) | -89.86%(-15.1%) |
| Sep 2015 | - | -105.81%(-83.7%) |
| Jun 2015 | - | -647.55%(-389.3%) |
| Mar 2015 | - | 223.82%(+916.0%) |
| Dec 2014 | 21.16%(-30.4%) | 22.03%(-6.4%) |
| Sep 2014 | - | 23.54%(+31.1%) |
| Jun 2014 | - | 17.96%(+27.4%) |
| Mar 2014 | - | 14.10%(+61.5%) |
| Dec 2013 | 30.41%(+9.0%) | 8.73% |
| Dec 2012 | 27.90% | - |
FAQ
- What is TRACON Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for TRACON Pharmaceuticals?
- What is TRACON Pharmaceuticals annual ROE year-on-year change?
- What is TRACON Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for TRACON Pharmaceuticals?
- What is TRACON Pharmaceuticals quarterly ROE year-on-year change?
What is TRACON Pharmaceuticals annual return on equity?
The current annual ROE of TCON is 443.51%
What is the all time high annual ROE for TRACON Pharmaceuticals?
TRACON Pharmaceuticals all-time high annual return on equity is 443.51%
What is TRACON Pharmaceuticals annual ROE year-on-year change?
Over the past year, TCON annual return on equity has changed by +1720.52% (+134.73%)
What is TRACON Pharmaceuticals quarterly return on equity?
The current quarterly ROE of TCON is -237.65%
What is the all time high quarterly ROE for TRACON Pharmaceuticals?
TRACON Pharmaceuticals all-time high quarterly return on equity is 615.11%
What is TRACON Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, TCON quarterly return on equity has changed by -284.39% (-608.45%)